|
T. gondii mic2 mutant vaccine |
T. gondii OMPDC mutant vaccine |
T. gondii OMPDC/UP mutant vaccine |
| Vaccine Information |
Vaccine Information |
Vaccine Information |
- Vaccine Ontology ID: VO_0003012
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- mic2
gene engineering:
- Immunization Route: Intraperitoneal injection (i.p.)
|
- Vaccine Ontology ID: VO_0003013
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- OMPDC
gene engineering:
- Type: Gene mutation
- Description: This OMPDC mutant is from Toxoplasma gondii (Fox and Bzik, 2010).
- Detailed Gene Information: Click Here.
- Immunization Route: Intraperitoneal injection (i.p.)
|
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- OMPDC
gene engineering:
- Type: Recombinant protein preparation
- Description: This OMPDC/UP mutant is from Toxoplasma gondii (Fox and Bzik, 2010).
- Detailed Gene Information: Click Here.
- UP
gene engineering:
- Type: Gene mutation
- Description: This OMPDC/UP mutant is from Toxoplasma gondii (Fox and Bzik, 2010).
- Detailed Gene Information: Click Here.
- Immunization Route: Intraperitoneal injection (i.p.)
|
| References |
References |
References |
Huynh and Carruthers, 2006: Huynh MH, Carruthers VB. Toxoplasma MIC2 is a major determinant of invasion and virulence. PLoS pathogens. 2006; 2(8); e84. [PubMed: 16933991].
|
Fox and Bzik, 2010: Fox BA, Bzik DJ. Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii. Infection and immunity. 2010; 78(9); 3744-3752. [PubMed: 20605980].
|
Fox and Bzik, 2010: Fox BA, Bzik DJ. Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii. Infection and immunity. 2010; 78(9); 3744-3752. [PubMed: 20605980].
|
